ESC Professional Premium Access

Cardioprotection beyond the guidelines: the SAFE trial results

Topic: Cardiotoxicity of Drugs and Other Therapies

Congress Presentation

About the speaker

Doctor Giuseppe Barletta

Careggi University Hospital (AOUC), Florence (Italy)
0 follower

5 more presentations in this session

Mitochondrial dynamics and myocardial metabolism alterations during anthracycline-cardiotoxicity

Speaker: Miss A. Diaz-Guerra Priego (Madrid, ES)

Thumbnail

Adult survivors of childhood cancer have significant levels of impaired cardiorespiratory fitness, inflammatory markers and poor quality of life outcomes

Speaker: Doctor C. McCune (Belfast, GB)

Thumbnail

Establishment of an in vivo murine model of immune checkPoint inhibitors cardiotoxicity: emerging role of vascular permeability in pembrolizumab-induced cardiotoxicity.

Speaker: Doctor P. Efentakis (Athens, GR)

Thumbnail

Association between vitamin D receptor gene polymorphism and cardiomyopathy in response to adriamycin treatment among breast cancer patients

Speaker: Miss R. Mokhtar (Cairo, EG)

Thumbnail

Association between immune checkpoint inhibitors and heart failure hospitalizations: a population-based self-controlled case series

Speaker: Professor G. Tse (Hong Kong, CN)

Thumbnail

Access the full session

Cardiotoxicity of cancer therapies

Speakers: Doctor G. Barletta, Miss A. Diaz-Guerra Priego, Doctor C. McCune, Doctor P. Efentakis, Miss R. Mokhtar...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations